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Research
Exposure to fine particulate matter [aero-
dynamic diameter ≤ 2.5 µm (PM2.5)] has 
been associated with cardiovascular outcomes, 
including myocardial infarctions (Peters 
et al. 2001; Tonne et al. 2007; Zanobetti 
and Schwartz 2005), endothelial dysfunction 
(O’Neill et al. 2007), and electrocardiographic 
ST segment depression (Gold et al. 2000), but 
the mechanisms responsible for these associa-
tions have not been not fully elucidated. Several 
epidemiologic studies have reported associa-
tions between PM air pollution and autonomic 
changes measured by heart rate variability 
(Chuang et al. 2007; Luttmann-Gibson et al. 
2006; Schwartz et al. 2005) and have shown 
that this association is modified by genetic poly-
morphisms (Chahine et al. 2007). Air pollution 
has also been associated with vasoconstriction 
(Brook et al. 2002) and increases in blood pres-
sure (Ibald-Mulli et al. 2001), suggesting effects 
on blood   pressure control.
Postural change in blood pressure is a 
measure of cardiovascular reactivity reflecting 
autonomic function indicated by baroreflex-
mediated feedback. Movement from a supine 
or sitting position to standing causes a rapid 
loss of blood from the thoracic and abdominal 
cavities and pooling in the extremities, reduc-
ing venous return and cardiac stroke volume. 
Under normal conditions, this stimulates 
baroreceptors to activate the sympathetic ner-
vous system, leading to vasoconstriction and 
increased heart rate to maintain a stable blood 
pressure as parasympathetic nerve signals to 
the heart are withdrawn, thus causing short-
term blood pressure changes. Although up-
regulation of sympathetic activity is necessary 
for regulation of blood pressure, hyperreactiv-
ity is associated with harmful effects, including 
the development of hypertension.
Because chronic lung disease is associ-
ated with many processes also involved with 
cardiovascular disease, we hypothesized that 
genes originally selected for study of chronic 
obstructive pulmonary disease (COPD) and 
asthma would influence postural change in 
blood pressure and interact with effects of 
PM on this measure. Asthma and COPD are 
well-established diseases of immune response, 
and evidence has linked these conditions with 
the autonomic and immune systems (Mignini 
et al. 2003) in addition to demonstrating 
that the renin–angiotensin system is acti-
vated in severe asthma (Ramsay et al. 1997). 
Polymorphic variation may make some indi-
viduals more vulnerable to the effects of PM 
exposure, and PM has been associated with 
increases in systolic blood pressure (SBP)
(Ibald-Mulli et al. 2001). Therefore, we pre-
dicted that these interactions may play a role 
in postural blood pressure changes as well.
Materials and Methods
Study population. This study uses data from 
the Normative Aging Study (NAS), details of 
which have been published previously (Bell 
et al. 1970). Briefly, the NAS is an ongoing 
longitudinal cohort study of aging established 
by the Veterans Administration in 1963. A 
total of 2,280 men from the Greater Boston 
area (21–80 years of age) confirmed to be 
free of known chronic medical conditions 
were enrolled, and participants were asked 
to return for examinations every 3–5 years. 
Study center visits took place in the morn-
ing, after overnight fast and abstention from 
smoking. Physical examinations included 
measurement of height and weight, and body 
mass index (BMI) was calculated as weight 
(in kilograms) divided by height (in square 
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Ba c k g r o u n d: Fine particulate matter [aerodynamic diameter ≤ 2.5 µm (PM2.5)] has been associated 
with autonomic dysregulation. 
oB j e c t i v e: We hypothesized that PM2.5 influences postural changes in systolic blood pressure 
(∆SBP) and in diastolic blood pressure (∆DBP) and that this effect is modified by genes thought to 
be related to chronic lung disease. 
Me t h o d s : We measured blood pressure in participants every 3–5 years. ∆SBP and ∆DBP were 
calculated as sitting minus standing SBP and DBP. We averaged PM2.5 over 48 hr before study visits 
and analyzed 202 single nucleotide polymorphisms (SNPs) in 25 genes. To address multiple com-
parisons, data were stratified into a split sample. In the discovery cohort, the effects of SNP × PM2.5 
interactions on ∆SBP and ∆DBP were analyzed using mixed models with subject-specific random 
intercepts. We defined positive outcomes as p < 0.1 for the interaction; we analyzed only these SNPs 
in the replicate cohort and confirmed them if p < 0.025 with the same sign. Confirmed associations 
were analyzed within the full cohort in models adjusted for anthropometric and lifestyle factors. 
re s u l t s: Nine hundred forty-five participants were included in our analysis. One interaction with 
rs9568232 in PHD finger protein 11 (PHF11) was associated with greater ∆DBP. Interactions with 
rs1144393 in matrix metalloprotease 1 (MMP1) and rs16930692, rs7955200, and rs10771283 in 
inositol 1,4,5-triphosphate receptor, type 2 (ITPR2) were associated with significantly greater ∆SBP. 
Because SNPs associated with ∆SBP in our analysis are in genes along the renin–angiotensin path-
way, we then examined medications affecting that pathway and observed significant interactions for 
angiotensin receptor blockers but not angiotensin-converting enzyme inhibitors with PM2.5. 
co n c l u s i o n s: PM2.5 influences blood pressure and autonomic function. This effect is modified by 
genes and drugs that also act along this pathway.
key w o r d s : aging and susceptible populations, blood pressure, environmental epidemiol-
ogy, gene–environment interaction, particulate matter. Environ Health Perspect 117:935–940 
(2009).  doi:10.1289/ehp.0800279 available via http://dx.doi.org/ [Online 3 February 2009]936  v o l u m e  117 | n u m b e r 6 | June 2009  •  Environmental Health Perspectives
Wilker et al.
meters). Questionnaires evaluated smoking 
habits and medication use, with responses 
confirmed by an on-site physician. Subjects 
indicated pulmonary disorders by a question-
naire based on the American Thoracic Society 
Division of Lung Diseases 1978 questionnaire 
(Ferris 1978). Participants provided written 
informed consent, and the study protocol was 
approved by the institutional review boards of 
all participating institutions. Subjects visited 
the study center during the study period from 
1995–2006 one to four times: 945 subjects 
(45%) had one visit, 692 subjects (33%) had 
two visits, 425 subjects (20%) had three visits, 
and 36 subjects (2%) had four visits.
Blood pressure measurements. At each 
clinical visit, a physician measured blood pres-
sure using a standard mercury sphygmoma-
nometer. SBP and fifth-phase diastolic blood 
pressure (DBP) were measured in each arm to 
the nearest 2 mmHg while the participant was 
seated. The means of the right and left arm 
measurements were used as each participant’s 
SBP and DBP. A measure of standing blood 
pressure was recorded in the right arm 30 sec 
after standing. Previous studies have noted 
that most hemodynamic changes related to 
the assumption of standing posture occur 
within the first 30 sec (Akselrod et al. 1997; 
Smith et al. 1994), and the NAS protocol was 
designed to address these initial orthostatic 
changes. Postural changes in SBP and DBP 
were calculated as mean sitting minus stand-
ing for SBP (∆SBP) and DBP (∆DBP).
Air pollution measurement. Ambient 
PM2.5 were measured beginning in 1995 on 
the roof of Countway Library at Harvard 
Medical School. PM2.5 concentrations were 
measured using Tapered Element Oscillating 
Microbalance (model 1400A; Rupprecht & 
Pasternack, Albany, NY) operated at 50°C with 
a PM2.5 impactor (Air Diagnostics, Harrison, 
ME) with two plates. Air was drawn through 
the impactors at 4 LPM. Concentrations 
(microgram per cubic meter) were averaged 
into 30-min periods. For this study, we esti-
mated exposures as the 48-hr average con-
centration before study visit and blood draw. 
This time period has shown to have strongest 
associations with heart rate variability, another 
measure of autonomic function, within this 
cohort (Park et al. 2005).
Single nucleotide polymorphism selection 
and genotyping. We chose candidate genes 
based on their known or suspected roles in the 
etiology of COPD and asthma from previous 
positional cloning and candidate gene stud-
ies (Poon et al. 2007a, 2007b). A total of 202 
single nucleotide polymorphisms (SNPs) in 
25 genes were available for this analysis, which 
took advantage of another project that had 
extensively genotyped genes suspected of being 
related to chronic lung disease. SNPs were 
located in genes associated with lung inflam-
mation, protease/antiprotease imbalance, oxi-
dative stress, and extracellular matrix synthesis 
or destruction. We also selected tagging SNPs 
with r2 > 0.80 and minor allele frequency 
(MAF) > 5%, covering 5 kb upstream and 
downstream of the first and last exons of each 
gene, nonsynonymous amino acid change with 
MAF > 1%, and known variants associated 
with asthma and related phenotypes. Table 1 
lists the 25 genes associated with these SNPs.
For genotyping we used BeadStation 500G 
(Illumina Inc., San Diego, CA) in the first stage 
(discovery cohort) and replicated results either 
with Sequenom MassArray matrix-assisted 
laser desorption/ionization time-of-flight mass 
spectrometer (Sequenom, San Francisco, 
CA) with semi  automated primer design 
(SpectroDESIGNER, Sequenom) and imple-
mentation of the very short extension method 
(Sun et al. 2000), or with TaqMan 5´ exonu-
clease with primers from Applied Biosystems 
Inc. (Foster City, CA) using radioactively 
labeled probes detected using ABI PRISM 
7900 Sequence Detector System (Applied 
Biosystems Inc.).
Population stratification was assessed using 
101 unlinked SNPs chosen from the Celera 
data set on the SNP Consortium Web site 
(http://snp.cshl.org/). We tested identity-by-
descent clustering using the PLINK tool set 
version 2 (http://pngu.mgh.harvard.edu/pur-
cell/plink/; Purcell et al. 2007). SNPs included 
in the stratification panel had Illumina scores 
≥ 0.65, indicating a high likelihood of successful 
genotyping, and a MAF ≥ 0.25 in Caucasians, 
and did not map to a gene in SNPper (http://
snpper.chip.org/). SNPs fewer than 100 kb 
apart, or those located on X-chromosome or 
on chromosomes 2q, 8p, 12p, 19q were not 
included in the population stratification analy-
sis because these regions are thought to be in 
linkage for chronic lung disease and, by defini-
tion, would be expected to differ within the 
  population based on disease conditions.
Statistical methods. Multiple comparisons 
is a major issue in genetic association stud-
ies. To address this issue, we used a two-stage 
strategy, dividing the study population into 
a discovery cohort and a replication cohort. 
The rationale for this approach is that random 
chance can create false associations in either 
cohort, but because it is random there is no 
reason to expect the same SNPs to have the 
same false associations in both cohorts. We 
defined change in blood pressure as standing 
minus sitting blood pressure, so that a negative 
number indicated a drop in blood pressure. 
Models of ∆SBP and ∆DBP were analyzed 
using linear mixed effect models with ran-
dom intercepts for individual subjects; in each 
model, we included terms for an individual 
SNP, PM2.5, and SNP × PM2.5 interaction 
adjusted for age and BMI. Genotypes (wild-
type and heterozygous and homozygous vari-
ants) were coded using categorical variables 
(levels 0, 1, 2) for testing under an additive 
model, and as binary variables (0, 1) for test-
ing under dominant and recessive models. The 
entire SNP set was analyzed in the discovery 
cohort and SNP × PM2.5 interactions associ-
ated with postural change in blood pressure 
at the p < 0.1 level were selected for testing 
in the replication cohort. We analyzed only 
these associations in the replication cohort 
and confirmed associations that were repli-
cated in the same direction as in the discovery 
cohort (positive or negative in both data sets) 
with a p < 0.025 in the replication cohort. 
Table 1. Candidate genes included in our analysis.
Gene  Name  Chromosome position
ITGB6  integrin, beta 6  2:q24.2
ITGAV  integrin alpha-V precursor  2:q32.1
IL6  interleukin 6 (interferon, beta 2)  7:p15.3
DEFB1  defensin, beta 1 preproprotein  8:p23.1
TLR4  toll-like receptor 4 precursor  9:q33.1
MBL2  soluble mannose-binding lectin precursor  10:q21.1
SFTPD  pulmonary surfactant-associated protein D  10:q22.3
GSTP1  glutathione transferase  11:q13.2
MMP1  matrix metalloproteinase 1 preproprotein  11:q22.2
MMP12  matrix metalloproteinase 12 preproprotein  11:q22.2
ITPR2  inositol 1,4,5-triphosphate receptor, type 2  12:p11.23
VDR  vitamin D (1,25-dihydroxyvitamin D3) receptor  12:q13.11
DCN  decorin isoform b precursor  12:q21.33
PHF11  PHD finger protein 11  13:q14.3
SERPINA3  serpin peptidase inhibitor, clade A, member 3  14:q32.13
SERPINA1  serine (or cysteine) proteinase inhibitor, clade  14:q32.13
IL4R  interleukin 4 receptor alpha chain isoform b  16:p12.1
CRHR1  corticotropin releasing hormone receptor 1  17:q21.31
AZU1  azurocidin 1 preproprotein  19:p13.3
ELA2  elastase 2, neutrophil preproprotein  19:p13.3
TGFB1  transforming growth factor, beta 1  19:q13.2
IL11  interleukin 11 precursor  19:q13.42
ADAM33  ADAM metallopeptidase domain 33 isoform alpha  20:p13
MMP9  matrix metalloproteinase 9 preproprotein  20:q13.12
SLPI  secretory leukocyte peptidase inhibitor  20:q13.12Environmental Health Perspectives  •  v o l u m e  117 | n u m b e r 6 | June 2009  937
Postural blood pressure change
Confirmed associations were then examined 
in models adjusted for age, BMI, smoking 
status (never, current, former), blood urea 
nitrogen, individual class of hypertension 
medication use [beta blockers, angiotensin 
receptor blockers (ARBs), alpha blockers, 
angiotensin-converting enzyme (ACE) inhibi-
tors, and calcium channel blockers], and dia-
betes diagnosis in the full cohort data.
The splitting of the sample and use of 
confirmation in the replication cohort pro-
vide protection against false positives. Because 
of the correlations in the data among SBP 
and DBP, repeated measures, and SNPs, the 
exact false discovery rate under this procedure 
cannot be computed theoretically. Instead, 
we examined false-positive predictive rates 
in a simulation study that preserved the cor-
relation structure among SNPs and outcomes 
present in the data. The genotype data for 
each subject was randomly permuted, and 
then merged back into the repeated measures 
of phenotype. We created 10 new simulation 
data sets in which any associations observed 
in each individual simulation were random. 
We then identified all SNPs within each of 
the 10 discovery simulations that met our cri-
teria of a p < 0.1 for the SNP × PM2.5 inter-
action and analyzed them in the simulated 
replication data set. We defined the probabil-
ity of observing each of the associations we 
saw in the true data set as the probability of 
observing a greater absolute value t-statistic in 
the replication arm of the simulation study.
Results
A total of 945 individuals with a total of 
2,098 study visits provided complete covari-
ate and genotype data and are included in 
this analysis. A total of 480 subjects were ran-
domly assigned to the discovery data set and 
465 to the replicate data set. Table 2 pres-
ents the distribution of their demographics 
and anthropometrics. Age (mean ± SD) of 
study participants was 71.0 ± 7.3 years in the 
discovery cohort and 71.6 ± 7.1 years in the 
replication cohort, and most participants were 
former smokers. The distributions of a history 
of diabetes and use of medications for hyper-
tension were similar in both cohorts.
We first examined the main effects of 
PM2.5 in mixed models adjusted for all cova-
riates. The effect of PM2.5 in the model for 
∆DBP was associated with a –0.018 mmHg 
change [95% confidence interval (CI), –0.45 
to 0.41]. The main effect of PM2.5 in the 
model for ∆SBP was 0.69 mmHg (95% CI, 
–0.15 to 1.53). Both of these results are non-
significant, although the ∆SBP change was 
more suggestive of an association.
All of the SNPs that met our criteria for 
an association in analyses were in Hardy–
Weinberg equilibrium. Table 3 presents the 
distribution and Hardy–Weinberg equilibrium 
chi-square test results and p-values for SNPs 
that met the criteria in our models. The 
rs9568232 SNP in PHD finger protein 11 
(PHF11) met our criteria for an SNP × PM2.5 
interaction predictive of ∆DBP. Criteria for 
SNP × PM2.5 interactions predictive of ∆SBP 
were met by rs114493 in matrix-mettalo-
protease 1 (MMP1) as well as rs16930692, 
rs7955200, and rs10771283 in the inositol 
1,4,5-triphosphate receptor, type 2 (ITPR2).
We examined SNP × PM2.5 inter  actions 
under additive, dominant, and recessive 
  models of inheritance, and in our ∆DBP 
models 32 associations in 21 SNPs met cri-
teria for ∆DBP in the discovery data set and 
were replicated. Of these associations, one 
SNP in the PHF11 gene met criteria for a 
significant SNP × PM2.5 interaction. Under a 
dominant model, the C/T PHF11 rs9568232 
SNP × PM2.5 interaction was associated with 
2.29 mmHg higher DBP upon standing (95% 
CI, 0.72–3.86). Neither the main effect of 
PM2.5 (–0.3 mmHg; 95% CI, –0.79 to 0.19) 
nor rs9568232 (0.37 mmHg; 95% CI, –0.49 
to 1.23) was significant in the model.
In our SBP models, 46 associations in 34 
SNPs met criteria at the 0.1 level for ∆SBP in 
the discovery data set. Of these associations, 
four SNP × PM2.5 interactions met criteria for 
significant changes in ∆SBP (Table 4). Under 
a recessive model of inheritance, the SNP × 
PM2.5 interaction for the rs1144393 C/T SNP 
in MMP1 was associated with a 3.40 mmHg 
higher ∆SBP (95% CI, 0.79–6.01). Both main 
effects for the SNP and PM2.5 were not signifi-
cant at the mean level of PM2.5 exposure.
Three SNPs in ITPR2 met criteria for 
an association with ∆SBP modified by the 
effect of PM2.5. Under a dominant model, 
the SNP × PM2.5 interaction for the minor C 
allele of A/C rs16930692 was associated with 
3.48 mmHg higher SBP upon standing (95% 
CI, 0.84–6.12). Similarly, under a recessive 
model, the SNP × PM2.5 interaction for the T 
variant of the C/T rs7955200 SNP in ITPR2 
was associated with a 4.84 mmHg higher SBP 
upon standing (95% CI, 1.47–8.20). Finally, 
for the G minor allele of the rs10771283 A/G 
SNP, we observed 5.7 mmHg higher ∆SBP 
(95% CI, 1.71–9.69). For all three ITPR2 
Table 2. Anthropometric and clinical characteristics and postural change in blood pressure parameters of 
the study subjects. 
  Discovery cohort (n = 480)  Replication cohort (n = 465)
Characteristic  Status  Mean ± SD  No. (%)  Mean ± SD  No. (%)
Age (years)    71 ± 7.3    71.6 ± 7.1
BMI (m/kg2 )     28 ± 3.9    27.9 ± 4
∆DBP (mmHg)    0.7 ± 6.4    0.5 ± 6.5
∆SBP (mmHg)    –2.7 ± 12.9    –1.6 ± 12.5
PM 48 hr (µg/m3 )    11.9 ± 6.1    11.8 ± 6
Smoking  Never    157 (32.71)    143 (30.75)
   Current    25 (5.21)    29 (6.24)
   Former    298 (62.08)    293 (63.01)
Diabetes diagnosis  No    374 (77.92)    351 (75.48)
   Yes    106 (22.08)    114 (24.52)
Alpha blockers  No    393 (81.88)    389 (83.66)
   Yes    87 (18.13)    76 (16.34)
Angiotensin receptor blocker   No    451 (93.96)    430 (92.47)
   Yes    29 (6.04)    35 (7.53)
ACE inhibitors  No    329 (68.54)    334 (71.83)
   Yes    151 (31.46)    131 (28.17)
Calcium channel blockers  No    358 (74.58)    360 (77.42)
  Yes    122 (25.42)    105 (22.58)
Beta blockers  No    287 (59.79)    283 (60.86)
   Yes     193 (40.21)     182 (39.14)
Table 3. Characteristics of SNPs with confirmed associations and their distribution among study 
  participants.
Characteristic  PHF11  MMP1  ITPR2  ITPR2  ITPR2
Rs number  rs9568232  rs1144393  rs16930692  rs7955200  rs10771283
Chromosome  chr13  chr11  chr12  chr12  chr12
Location  48987845  102174619  26477273  26477096  26478845
SNP  C/T  C/T  A/C  C/T  A/G
Functional role  Intron  Promoter  Intron  Intron  Intron
Wild type  814  351  802  480  571
Heterozygote  120  439  119  362  307
Homozygote  3  127  3  82  47
Total  937  917  924  924  925
HWE χ2   0.162  1.33  0.16  1.3  0.47
 p -Value  0.69a  0.35  0.70a  0.25  0.49
HWE, Hardy–Weinberg equilibrium.
aYates continuity corrected where expected value < 5.Wilker et al.
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SNPs, main effects of the SNPs and PM2.5 
were not significant.
Because these ∆SBP associations for SNP 
× PM2.5 interactions were observed in genes 
related to the renin–angiotensin system, we 
hypothesized that blood pressure medications 
such as ARBs and ACE inhibitors might also 
be modified by the effects of PM2.5. We then 
examined associations for medication × PM2.5 
interactions in the full cohort by adding inter-
action terms for medication × PM2.5 sepa-
rately to the models that met our criteria for 
SNP × PM2.5 interactions (Table 4). Significant 
ARB × PM2.5 interactions (p < 0.05) were 
observed for all of the SNPs that met criteria for 
∆SBP SNP × PM2.5 interactions, which were 
previously confirmed through our two-stage 
analysis utilizing the split-sample approach. 
In these models, the coefficients for the ARB 
× PM2.5 inter  actions were associated with sig-
nificantly higher ∆SBP, whereby the magnitude 
of increase for an increase in 10 µg/m3 above 
the mean level of PM2.5 exposure was associated 
with 8–9 mmHg higher SBP. Similar results 
were observed for ARB × PM2.5 interactions in 
the absence of any SNP, where the interaction 
was associated with a 7.16 mmHg higher SBP 
(95% CI, 1.09–13.22). Figure 1 displays the 
relationship between SNP × PM2.5 interactions 
and ARB × PM2.5 interactions for ∆SBP. ACE 
inhibitors and their interactions with PM2.5 did 
not significantly alter ∆SBP.
Using our simulations, we found that 
the adjusted p-value for the SNP × PM2.5 
association observed for the rs9568232 SNP 
in PHF11 was 0.01. The rs1144393 MMP1 
SNP × PM2.5 interaction associated with 
∆SBP had an adjusted p-value of 0.02. The 
adjusted p-values for both the rs16930692 
and rs10771283 ITPR2 SNP × PM2.5 inter-
actions were 0.012, and for rs7955200 the 
adjusted p-value for the SNP × PM2.5 inter-
action was 0.004.
Discussion
In this study of the effects of SNP × PM2.5 
interactions predicting postural changes in 
blood pressure, we observed several significant 
associations suggesting autonomic dysregula-
tion and sensitization related to genes acting 
along the renin–angiotensin pathway in the 
presence of PM2.5, in contrast to the typical 
physiologic responses, in which we would 
expect to observe very small perturbations in 
blood pressure, and even negative associations 
with initial orthostatic change. Interactions 
in this analysis were consistently associated 
with increases in blood pressure from sitting to 
standing. In models of ∆DBP we observed one 
SNP × PM2.5 interaction that was a significant 
predictor, whereas in ∆SBP models, a single 
SNP in MMP1 and three SNPs in ITPR2 met 
our criteria. ITPR2 and MMP1 are activated 
downstream from angiotensin II and may be 
involved in altering responsiveness to renin–
angiotensin and subsequent vasoconstriction 
with chronic exposure. Our analysis including 
PM2.5 interactions with antihypertension med-
ication use among study participants showed 
similar effects where both SNP × PM2.5 inter-
actions and ARB × PM2.5 interactions were 
associated with greater increase in blood pres-
sure from sitting to standing position.
Although angiotensin II sensitization is nec-
essary for regulation of blood pressure, hyper-
reactivity is associated with harmful effects, 
including the development of hypertension. 
Recent studies suggest that PM2.5 introduces 
cardiovascular effects by blunting response 
to endothelial dependent agonists as well as 
increasing response to vaso  constrictors in ani-
mals (Sun et al. 2005). In humans, evidence 
has shown that PM alters vascular diameter 
and tone and is associated with narrowing of 
the brachial artery (Brook et al. 2002) in con-
trolled laboratory settings. Although epidemio-
logic studies have observed conflicting results in 
response to the effects of PM2.5 on blood pres-
sure, two recent reports have observed small 
but significant increases in blood pressure asso-
ciated with exposure (Auchincloss et al. 2008; 
Zanobetti et al. 2004). Our results suggest that 
looking at main effects of genes alone may not 
be sufficient and also may help to explain why 
associations between PM2.5 and various cardio-
vascular outcomes have been inconsistent.
Table 4. Results for ∆SBP SNP × PM2.5 interaction models and ARB and ACE inhibitor interactions.a
    Model 1:   Model 2: model 1 +  Model 3: model 1 +
    SNP × 10 µg/m3 PM2.5    ARB × 10 µg/m3 PM2.5   ACE inhibitor × 10 µg/m3 PM2.
Gene  Variable  β (95% CI)  β (95% CI)  β (95% CI)
MMP1
Recessive  Rs1144393  0.37 (–1.34 to 2.08)  0.35 (–1.36 to 2.06)  0.38 (–1.33 to 2.09)
  10 µg/m3 PM2.5  0.2 (–0.80 to 1.20)  0.04 (–0.96 to 1.04)  0.35 (–0.73 to 1.43)
   Rs1144393 × 10 µg/m3 PM2.5  3.4 (0.79 to 6.01)  3.35 (0.74 to 5.96)  3.46 (0.85 to 6.07)
   ARB     2.76 (–0.57 to 6.09)
   ARB × 10 µg/m3 PM2.5     8.64 (2.00 to 15.28)
   ACE inhibitors       –0.26 (–1.75 to 1.23)
   ACE inhibitors × 10 µg/m3 PM2.5       –0.83 (–3.20 to 1.54)
ITPR2
Dominant  Rs16930692   –1.07 (–2.75 to 0.61)  –1.06 (–2.74 to 0.62)  –1.07 (–2.75 to 0.61)
   10 µg/m3 PM2.5  0.28 (–0.72 to 1.28)  0.12 (–0.89 to 1.12)  0.42 (–0.67 to 1.52)
   Rs16930692 × 10 µg/m3 PM2.5  3.48 (0.84 to 6.12)  3.47 (0.84 to 6.10)  3.45 (0.81 to 6.09)
   ARB     2.89 (–0.45 to 6.23)
   ARB × 10 µg/m3 PM2.5    8.68 (2.03 to 15.32)
   ACE inhibitors       –0.19 (–1.68 to 1.30)
   ACE inhibitors × 10 µg/m3 PM2.5       –0.74 (–3.12 to 1.63)
Recessive   Rs7955200  –0.73 (–2.77 to 1.30)  –0.75 (–2.78 to 1.29)  –0.74 (–2.77 to 1.30)
   10 µg/m3 PM2.5  0.33 (–0.63 to 1.29)  0.18 (–0.79 to 1.15)  0.44 (–0.63 to 1.51)
   Rs7955200 × 10 µg/m3 PM2.5  4.84 (1.47 to 8.20)  4.65 (1.29 to 8.01)  4.79 (1.42 to 8.16)
   ARB     2.87 (–0.47 to 6.20)
   ARB × 10 µg/m3 PM2.5     8.35 (1.69 to 15.01)
   ACE inhibitors       –0.3 (–1.79 to 1.19)
   ACE inhibitors × 10 µg/m3 PM2.5       –0.58 (–2.95 to 1.80)
Recessive   Rs10771283   –1.29 (–3.82 to 1.23)  –1.29 (–3.82 to 1.23)  –1.3 (–3.83 to 1.23)
   10 µg/m3 PM2.5  0.41 (–0.55 to 1.36)  0.26 (–0.70 to 1.22)  0.51 (–0.55 to 1.57)
   Rs10771283 × 10 µg/m3 PM2.5  5.7 (1.71 to 9.69)  5.43 (1.44 to 9.41)  5.63 (1.63 to 9.63)
   ARB     2.88 (–0.46 to 6.21)
   ARB × 10 µg/m3 PM2.5     8.24 (1.58 to 14.90)
   ACE inhibitors       –0.31 (–1.81 to 1.18)
   ACE inhibitors × 10 µg/m3 PM2.5        –0.54 (–2.91 to 1.84)
aModels adjusted for age, BMI, smoking status, ACE inhibitors, ARBs, diabetes, alpha blockers, beta blockers, and calcium channel blockers. β is equivalent to mmHg. Postural blood pressure change
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We observed a number of associations 
for SNP × PM2.5 interactions as predictors 
of ∆SBP, but only one SNP met criteria in 
our models for an association with ∆DBP. 
PHF11 is located on chromosome 13 and is 
most commonly cited as an asthma candidate 
gene. A chromosomal region of 13q4 within 
which PHF11 is located has been previously 
associated with a linkage peak thought to be 
related to a site controlling both SBP postural 
change and BMI, a well-established predictor 
of blood pressure (Feitosa et al. 2002; North 
et al. 2004). One recent study has shown that 
asthmatics were 43% more likely to have heart 
disease and 36% more likely to have high 
blood pressure compared with nonasthmatics 
(Dogra et al. 2007), and adult-onset asthma 
has been demonstrated to be a significant pre-
dictor of atherosclerosis (Onufrak et al. 2007). 
The PHF11 gene has been associated with IgE 
regulation, and different splice variants of the 
gene are differentially expressed in B- and 
T-lymphocytes (Zhang et al. 2003).
Examination of the SNPs associated 
with ∆SBP in our models showed that both 
genes in which these SNPs are located also 
act along the renin–angiotensin pathway. The 
rs1144393 SNP in MMP1 SNP for which we 
observed an increase in ∆SBP via SNP × PM2.5 
effects is located in the promoter region of the 
gene, primarily responsible for expression of 
the protein. MMPs are involved in extracellu-
lar matrix remodeling, which is closely related 
to mechanisms of atherosclerosis and plaque 
disruption. Diesel particles are well-established 
inducers of oxidative stress and have been 
shown to induce MMP1 (Amara et al. 2007), 
providing further support for a functional rela-
tionship between the effects of MMP1 and 
cardiovascular outcomes. Also, angiotensin II 
has also been shown to induce expression of 
MMP1 in human vascular muscle cells (Kim 
et al. 2005).
ITPR2, for which three SNPs were sig-
nificant, is expressed widely in myocytes, and 
expression of these receptors is altered in heart 
failure, which suggests that the signaling mech-
anism associated with ITPR2 is responsible 
for critical cardiac functionality for contractil-
ity through the regulation of Ca2+ channels 
that are important in the maintenance of vas-
cular tone (Kockskamper et al. 2008). Also, 
angiotensin II is known to affect barorecep-
tors by releasing intercellular calcium through 
interaction with inositol triphosphate (Paton 
et al. 2001) and binds to cell surface receptors, 
which in turn directly activate ITPR2 to release 
intracellular calcium from the endoplasmic 
reticulum, triggering a further cascade result-
ing in vasoconstriction. The SNPs in which 
we observed an association are all located in 
intronic regions; although the functionality of 
these variants is not well understood, they may 
play a role in stability of the protein product, 
or they may be correlated with SNPs in other 
regions with significant effects.
Although we noted effect modification 
between ARBs and PM2.5 for both ITPR2 
and MMP1 SNPs, we observed no relation-
ship for the interaction with ACE inhibitors; 
this may be due to the site of action of ARBs 
being more immediately proximal to the trig-
gering of expression of these genes. Although 
the two classes of drugs ultimately produce 
similar effects in reducing blood pressure, 
they work by different mechanisms along the 
renin–angiotensin pathway. Sun et al. (2008) 
recently noted that treatment of rats with 
angiotensin II in conjunction with exposure 
to air pollution increased aortic vasoconstric-
tion, which is consistent with our observa-
tions. Interestingly, Li et al. (1998) found 
that losartan, an ARB, inhibits the vasocon-
striction effect of urban PM on human pul-
monary artery endothelial cells.
Although this study has produced a num-
ber of novel findings, we recognize that it 
also has some limitations. This study was 
not conducted using genomewide associa-
tion techniques but rather was performed 
on a subset of genes. We took advantage of 
another project that had extensively geno-
typed genes thought to be related to chronic 
lung disease, based on our belief that heart 
disease and chronic lung disease share many 
pathways. This limited our ability to study all 
the genes we might have been interested in 
if we had been able to examine genes related 
to blood pressure and baroreceptor response. 
However, we believe that the genes chosen for 
asthma and COPD are plausible candidates 
for these measures of autonomic function. 
We also considered the possibility that we 
observed our significant interactions because 
of associations between the sitting SBP, DBP, 
and mean arterial pressure effects alone, but 
analysis confirmed no significant association 
for any of the SNPs that met our criteria. 
These SNPs also were not associated with 
antihypertension medication use.
Although the ambient PM2.5 concen-
trations used in this analysis were obtained 
from a single monitoring site, because of 
the spatially homogeneous nature of PM2.5 
and previous evidence from a recent study 
demonstrating high longitudinal correlation 
between area concentrations and personal 
exposures (Sarnat et al. 2005), we believe that 
the single-site PM2.5 measurements should 
serve as a reasonable surrogate. In addition, 
misclassification of the air pollution moni-
toring data would be expected to be nondif-
ferential and thus attenuate the true PM2.5 
effect. Measurement error in our blood pres-
sure monitoring data would likely have a 
similar nondifferential effect, thereby decreas-
ing the likelihood of statistical significance. 
As a result, we could have missed some true 
associations between SNPs and biomarkers 
because our statistical approach is more sensi-
tive to false positives than to false negatives.
We have used a simple approach to measur-
ing autonomic function, and we have adopted 
stringent criteria for replication and calculated 
adjusted p-values using a permutation approach, 
allowing us to preserve the correlation struc-
ture within the data. We adopted this strategy 
rather than the classic Bonferroni correction 
method because the latter is not appropriate for 
testing associations within complex correlation 
structures and is designed to overlook true asso-
ciations at the expense of identifying spurious 
ones. Other procedures such as the widely used 
Benjamini and Hochberg (1995) false discovery 
rate use a modified Bonferroni approach to be 
less conservative, but even these tests generally 
assume independence or only weak correlation. 
In this analysis, there is correlation between 
the postural change in blood pressure measure-
ments and the repeated measures of the blood 
pressure measurements within each subject. 
Additionally, the density of SNPs selected 
within genes for this analysis suggests high 
probability of genetic linkage, and it is pos-
sible that some of the associations we observed 
may be markers of other functional regions. 
Correlation also exists because we have con-
ducted tests under additive, dominant, and 
recessive models of inheritance. The use of a 
simulation approach is a simple yet compre-
hensive way to address multiple testing.
Conclusions
In this study of the effects of PM2.5 inter-
actions with asthma and COPD candidate 
genes and hypertension medication use on 
∆SBP and ∆DBP, we observed significant 
effect modification by PM for several genes 
and for ARB use. Because we have examined 
these associations under a situation in which 
we are using outcomes measured on a con-
tinuous scale and with repeated measures, we 
have increased power to detect novel asso-
ciations that might otherwise go unobserved. 
Response to air pollution and its effect on 
autonomic function may be mediated by 
Figure 1. Effect of PM2.5, SNPs, Angiotensin recep-
tor blocker (ARB), SNP × PM2.5 interactions, and 
ARB × PM2.5 interactions in models predicting 
∆SBP. We adjusted all models for age, BMI, smok-
ing status, ACE inhibitors, ARBs, diabetes, alpha 
blockers, beta blockers, and calcium channel 
blockers.
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the SNP variants we have identified and can 
be further investigated in case–control and 
cohort studies. Also, blunting of the effects 
of ARBs but not ACE inhibitors in response 
to air pollution merits increased attention in 
clinical settings.
RefeRences
Akselrod S, Oz O, Greenberg M, Keselbrener L. 1997. Autonomic 
response to change of posture among normal and mild-
hypertensive adults: Investigation by time-dependent 
spectral analysis. J Auton Nerv Syst 64(1):33–43.
Amara N, Bachoual R, Desmard M, Golda S, Guichard C, 
Lanone S, et al. 2007. Diesel exhaust particles induce 
matrix metalloprotease-1 in human lung epithelial cells via 
a NADP(H) oxidase/NOX4 redox-dependent mechanism. 
Am J Physiol Lung Cell Mol Physiol 293(1):L170–L181.
Auchincloss AH, Roux AV, Dvonch JT, Brown PL, Barr RG, 
Daviglus ML, et al. 2008. Associations between recent 
exposure to ambient fine particulate matter and blood 
pressure in the multi-ethnic study of atherosclerosis 
(MESA). Environ Health Perspect 116:486–491.
Bell B, Rose CL, Damon A. 1972. The Normative Aging Study: 
an interdisciplinary and longitudinal study of health and 
aging. Aging Hum Dev 3:5–17.
Benjamini Y, Hochberg Y. 1995. Controlling the false discovery 
rate: a practical and powerful approach to multiple test-
ing. J R Stat Soc Series B Stat Methodol 57(1):289–300.
Brook RD, Brook JR, Urch B, Vincent R, Rajagopalan S, 
Silverman F. 2002. Inhalation of fine particulate air pollu-
tion and ozone causes acute arterial vasoconstriction in 
healthy adults. Circulation 105(13):1534–1536.
Chahine T, Baccarelli A, Litonjua A, Wright RO, Suh H, Gold DR, 
et al. 2007. Particulate air pollution, oxidative stress genes, 
and heart rate variability in an elderly cohort. Environ 
Health Perspect 115:1617–1622.
Chuang KJ, Chan CC, Su TC, Lee CT, Tang CS. 2007. The effect 
of urban air pollution on inflammation, oxidative stress, 
coagulation, and autonomic dysfunction in young adults. 
Am J Respir Crit Care Med 176(4):370–376.
Dogra S, Ardern CI, Baker J. 2007. The relationship between 
age of asthma onset and cardiovascular disease in 
Canadians. J Asthma 44(10):849–854.
Feitosa MF, Borecki IB, Rich SS, Arnett DK, Sholinsky P, 
Myers RH, et al. 2002. Quantitative-trait loci influenc-
ing body-mass index reside on chromosomes 7 and 13: 
the national heart, lung, and blood institute family heart 
study. Am J Hum Genet 70(1):72–82.
Ferris BG. 1978. Epidemiology standardization project (American 
Thoracic Society). Am Rev Respir Dis 118(6):1–120.
Gold DR, Litonjua A, Schwartz J, Lovett E, Larson A, 
Nearing B, et al. 2000. Ambient pollution and heart 
rate variability. Circulation 101(11):1267–1273.
Ibald-Mulli A, Stieber J, Wichmann HE, Koenig W, Peters A. 
2001. Effects of air pollution on blood pressure: a population-
based approach. Am J Public Health 91(4):571–577.
Kim MP, Zhou M, Wahl LM. 2005. Angiotensin II increases 
human monocyte matrix metalloproteinase-1 through the 
AT2 receptor and prostaglandin E2: implications for ath-
erosclerotic plaque rupture. J Leukoc Biol 78(1):195–201.
Kockskamper J, Zima AV, Roderick HL, Pieske B, Blatter 
LA, Bootman MD. 2008. Emerging roles of inositol 1,4,5-
trisphosphate signaling in cardiac myocytes. J Mol Cell 
Cardiol 45(2):128–147.
Li P, Ferrario CM, Brosnihan KB. 1998. Losartan inhibits throm-
boxane A2-induced platelet aggregation and vascular con-
striction in spontaneously hypertensive rats. J Cardiovasc 
Pharmacol 32(2):198–205.
Luttmann-Gibson H, Suh HH, Coull BA, Dockery DW, Sarnat SE, 
Schwartz J, et al. 2006. Short-term effects of air pollution 
on heart rate variability in senior adults in Steubenville, 
Ohio. J Occup Environ Med 48(8):780–788.
Mignini F, Streccioni V, Amenta F. 2003. Autonomic innervation 
of immune organs and neuroimmune modulation. Auton 
Autacoid Pharmacol 23(1):1–25.
North KE, Rose KM, Borecki IB, Oberman A, Hunt SC, Miller 
MB, et al. 2004. Evidence for a gene on chromosome 
13 influencing postural systolic blood pressure change 
and body mass index. Hypertension 43(4):780–784.
O’Neill MS, Veves A, Sarnat JA, Zanobetti A, Gold DR, 
Economides PA, et al. 2007. Air pollution and inflammation 
in type 2 diabetes: a mechanism for susceptibility. Occup 
Environ Med 64(6):373–379.
Onufrak S, Abramson J, Vaccarino V. 2007. Adult-onset asthma 
is associated with increased carotid atherosclerosis 
among women in the atherosclerosis risk in communities 
(ARIC) study. Atherosclerosis 195(1):129–137.
Park SK, O’Neill MS, Vokonas PS, Sparrow D, Schwartz J. 
2005. Effects of air pollution on heart rate variability: the 
VA Normative Aging Study. Environ Health Perspect 
113:304–309.
Paton JFR, Deuchars J, Ahmad Z, Wong LF, Murphy D, 
Kasparov S. 2001. Adenoviral vector demonstrates that 
angiotensin II-induced depression of the cardiac barore-
flex is mediated by endothelial nitric oxide synthase in 
the nucleus tractus solitarii of the rat. J Physiol (Lond) 
531(2):445–458.
Peters A, Dockery DW, Muller JE, Mittleman MA. 2001. 
Increased particulate air pollution and the triggering of 
myocardial infarction. Circulation 103(23):2810–2815.
Poon AH, Gitin E, Houseman EA, Ryan L, Silverman, EK, Weiss 
ST, et al. 2007a. Genetic variants of COPD candidate genes 
are associated with longitudinal lung function decline in 
a general population sample of men [Abstract]. In Am J 
Respi Crit Care Med 175: A564
Poon AH, Gitin E, Houseman EA, Ryan L, Silverman, EK, Weiss 
ST, et al. 2007b. Genetic variants of asthma candidate 
genes are associated with longitudinal lung function 
decline in a general population sample of men [Abstract]. 
In Am J Respi Crit Care Med 175: A832
Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, 
Bender D, et al. 2007. PLINK: A tool set for whole-genome 
association and population-based linkage analyses. Am J 
Hum Genet 81(3):559–575.
Ramsay S, Dagg K, McKay I, Lipworth B, McSharry C, Thomson 
N. 1997. Investigations on the renin-angiotensin system in 
acute severe asthma. Eur Respir J 10(12):2766–2771.
Sarnat JA, Brown KW, Schwartz J, Coull BA, Koutrakis P. 2005. 
Ambient gas concentrations and personal particulate mat-
ter exposures: implications for studying the health effects 
of particles. Epidemiology 16(3):385–395.
Schwartz J, Park SK, O’Neill MS, Vokonas PS, Sparrow D, 
Weiss S, et al. 2005. Glutathione-S-transferase M1, obe-
sity, statins, and autonomic effects of particles: gene-by-
drug-by-environment interaction. Am J Respir Crit Care 
Med 172(12):1529–1533.
Smith JJ, Porth CM, Erickson M. 1994. Hemodynamic response 
to the upright posture. J Clin Pharmacol 34(5):375–386.
Sun Q, Wang A, Jin X, Natanzon A, Duquaine D, Brook RD, et al. 
2005. Long-term air pollution exposure and acceleration of 
atherosclerosis and vascular inflammation in an animal 
model. JAMA 294(23):3003–3010.
Sun Q, Yue P, Ying Z, Cardounel AJ, Brook RD, Devlin R, et al. 
2008. Air pollution exposure potentiates hypertension 
through reactive oxygen species-mediated activation of 
Rho/ROCK. Arterioscler Thromb Vasc Biol 28(10):1760–1766.
Sun X, Ding H, Hung K, Guo B, Journals O. 2000. A new MALDI-
TOF based mini-sequencing assay for genotyping of SNPS. 
Nucleic Acids Res 28(12):e68. 
Tonne C, Melly S, Mittleman M, Coull B, Goldberg R, 
Schwartz J. 2007. A case-control analysis of exposure to 
traffic and acute myocardial infarction. Environ Health 
Perspect 115:53–57.
Zanobetti A, Canner MJ, Stone PH, Schwartz J, Sher D, Eagan-
Bengston E, et al. 2004. Ambient pollution and blood 
pressure in cardiac rehabilitation patients. Circulation 
110(15):2184–2189.
Zanobetti A, Schwartz J. 2005. The effect of particulate air 
pollution on emergency admissions for myocardial infarc-
tion: a multicity case-crossover analysis. Environ Health 
Perspect 113(8):978–982.
Zhang Y, Leaves NI, Anderson GG, Ponting CP, Broxholme J, 
Holt R, et al. 2003. Positional cloning of a quantitative trait 
locus on chromosome 13q14 that influences immuno-
globulin E levels and asthma. Nat Genet 34(2):181–186.